A.B.M.F. Karim

624 total citations
17 papers, 434 citations indexed

About

A.B.M.F. Karim is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, A.B.M.F. Karim has authored 17 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Otorhinolaryngology and 4 papers in Oncology. Recurrent topics in A.B.M.F. Karim's work include Lung Cancer Diagnosis and Treatment (4 papers), Head and Neck Cancer Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A.B.M.F. Karim is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Head and Neck Cancer Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). A.B.M.F. Karim collaborates with scholars based in Netherlands, United States and Pakistan. A.B.M.F. Karim's co-authors include K.H. Njo, M. Bolla, Desmond Curran, Johan Menten, M E Silvestre, M. Piérart, E Nordman, N.K. Aaronson, E.H.J.M. Rutten and G.M. Kiebert and has published in prestigious journals such as The Lancet, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A.B.M.F. Karim

15 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.B.M.F. Karim Netherlands 8 248 167 138 89 64 17 434
E Yabumoto Japan 7 191 0.8× 111 0.7× 91 0.7× 122 1.4× 18 0.3× 14 374
Eric Yi-Liang Shen Taiwan 9 253 1.0× 87 0.5× 86 0.6× 100 1.1× 57 0.9× 27 441
Irving J. Weigensberg United States 8 248 1.0× 98 0.6× 230 1.7× 139 1.6× 69 1.1× 12 425
Mehul Patel United States 12 252 1.0× 160 1.0× 144 1.0× 156 1.8× 88 1.4× 31 717
Sujith Baliga United States 12 173 0.7× 97 0.6× 106 0.8× 114 1.3× 126 2.0× 64 404
Martha E. Southard United States 8 124 0.5× 92 0.6× 102 0.7× 85 1.0× 21 0.3× 14 395
R.C. Fogaroli Brazil 11 265 1.1× 68 0.4× 106 0.8× 70 0.8× 31 0.5× 46 383
James L. Leenstra United States 10 386 1.6× 143 0.9× 431 3.1× 164 1.8× 71 1.1× 18 752
Richard Cox United States 6 231 0.9× 83 0.5× 58 0.4× 132 1.5× 38 0.6× 6 365
Eric Ojerholm United States 12 223 0.9× 174 1.0× 136 1.0× 183 2.1× 24 0.4× 20 541

Countries citing papers authored by A.B.M.F. Karim

Since Specialization
Citations

This map shows the geographic impact of A.B.M.F. Karim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.B.M.F. Karim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.B.M.F. Karim more than expected).

Fields of papers citing papers by A.B.M.F. Karim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.B.M.F. Karim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.B.M.F. Karim. The network helps show where A.B.M.F. Karim may publish in the future.

Co-authorship network of co-authors of A.B.M.F. Karim

This figure shows the co-authorship network connecting the top 25 collaborators of A.B.M.F. Karim. A scholar is included among the top collaborators of A.B.M.F. Karim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.B.M.F. Karim. A.B.M.F. Karim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
4.
Kiebert, G.M., Desmond Curran, N.K. Aaronson, et al.. (1998). Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844). European Journal of Cancer. 34(12). 1902–1909. 202 indexed citations
5.
Tiwari, R. M., et al.. (1997). Treatment of cervical lymph node metastasis from an unknown primary tumor, with a review of the literature. Strahlentherapie und Onkologie. 173(3). 163–169. 7 indexed citations
6.
Slotman, Ben J., K.H. Njo, A. de Jonge, Otto W.M. Meijer, & A.B.M.F. Karim. (1993). Palliative radiotherapy in advanced metastatic and non-metastatic non-small cell lung cancer. Lung Cancer. 8(5-6). 285–292. 3 indexed citations
7.
Njo, K.H., et al.. (1993). Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer. 10(3-4). 221–228. 31 indexed citations
8.
Slotman, Ben J., K.H. Njo, A. de Jonge, Otto W.M. Meijer, & A.B.M.F. Karim. (1993). Hypofractionated radiation therapy in unresectable stage iii non-small cell lung cancer. Cancer. 72(6). 1885–1893. 26 indexed citations
9.
Terhaard, C., A.B.M.F. Karim, W.J. Hoogenraad, et al.. (1991). Local control in t3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model. International Journal of Radiation Oncology*Biology*Physics. 20(6). 1207–1214. 23 indexed citations
10.
Karim, A.B.M.F., et al.. (1990). A critical look at the TNM classification for laryngeal carcinoma. Cancer. 65(9). 1918–1922. 7 indexed citations
11.
Slotman, Ben J., A.B.M.F. Karim, & B. Ramanath Rao. (1990). Ovarian cancer: radiation sensitivity in vitro. Radiotherapy and Oncology. 19(4). 323–327. 5 indexed citations
12.
Koka, Venkata, R. M. Tiwari, I. van der Waal, et al.. (1989). Adenoid cystic carcinoma of the salivary glands: Clinicopathological survey of 51 patients. The Journal of Laryngology & Otology. 103(7). 675–679. 39 indexed citations
13.
Boven, Epie, Jan B. Vermorken, Henk van Deutekom, et al.. (1987). Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC). International Journal of Radiation Oncology*Biology*Physics. 13(11). 1735–1738. 27 indexed citations
14.
Keizer, H.J., A.B.M.F. Karim, K.H. Njo, et al.. (1984). Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapy. Radiotherapy and Oncology. 1(3). 227–234. 35 indexed citations
15.
Pinedo, Herbert M., et al.. (1983). Daily cis-dichlorodiammineplatinum (II) as a radio-enhancer: A preliminary toxicity report. Journal of Cancer Research and Clinical Oncology. 105(1). 79–82. 22 indexed citations
16.
Karim, A.B.M.F., et al.. (1980). Metronidazole as a radiosensitizer: A preliminary report on estimation in serum and saliva. International Journal of Radiation Oncology*Biology*Physics. 6(9). 1233–1236. 3 indexed citations
17.
Karim, A.B.M.F. & Ian Sutherland. (1976). RADIOTHERAPY AND CHEMOTHERAPY IN EARLY BREAST CANCER. The Lancet. 308(7975). 36–37. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Yabumoto Breakdown of academic impact, for papers by Eric Yi-Liang Shen Breakdown of academic impact, for papers by Irving J. Weigensberg Breakdown of academic impact, for papers by Mehul Patel Breakdown of academic impact, for papers by Sujith Baliga Breakdown of academic impact, for papers by Martha E. Southard Breakdown of academic impact, for papers by R.C. Fogaroli Breakdown of academic impact, for papers by James L. Leenstra Breakdown of academic impact, for papers by Richard Cox Breakdown of academic impact, for papers by Eric Ojerholm
Rankless by CCL
2026